Linde plc (LIN) Guidance & Earnings Results

On 2026-07-31 Linde plc raised guidance: "FY2026 adjusted EPS guidance raised to $17.70-$17.90 from prior range (not stated); Q3 2026 adjusted EPS guidance $4.45-$4.55; FY2026 capex…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LINLinde plcFollow LIN — free

Specialty Chemicals · Basic Materials

—

Price chart with a free account

Market cap: 234.6B
P/E TTM: 32.8
Dividend yield: 1.2%
52-week: —
Next earnings: 29 Oct, in 5 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
31 Jul 26	Raised	FY2026 adjusted EPS guidance raised to $17.70-$17.90 from prior range (not stated); Q3 2026 adjusted EPS guidance $4.45-$4.55; FY2026 capex $5.5B-$6.0B. · full year
1 May 26	Raised	FY2026 adj. EPS guidance $17.60-$17.90 (7-9% growth), Q2 adj. EPS $4.40-$4.50 (8-10% growth). · full year
5 Feb 26	Raised	FY2026 adj. EPS guidance $17.40-$17.90, +6-9% YoY; Q1 2026 adj. EPS $4.20-$4.30, +6-9% YoY
31 Oct 25	Raised	FY2025 adj. EPS $16.35-$16.45 (5-6% growth); Q4 2025 adj. EPS $4.10-$4.20 (+3-6% YoY) · full year
1 Aug 25	Reaffirmed	Q3 2025 adj. EPS $4.10-$4.20; FY2025 adj. EPS $16.30-$16.50; FY2025 capex $5.0B-$5.5B · full year

Linde plc — questions

What guidance did Linde plc give?: On 2026-07-31: "FY2026 adjusted EPS guidance raised to $17.70-$17.90 from prior range (not stated); Q3 2026 adjusted EPS guidance $4.45-$4.55; FY2026 capex $5.5B-$6.0B."
When does Linde plc report earnings?: Linde plc's next earnings report is expected on 2026-10-29.

Every figure on this page comes from Linde plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.